Senior Principal Biostatistician
Fulcrum Therapeutics, Massachusetts, United States
Disclosure information not submitted.
Interim Results of a Phase 1b study (PIONEER) of an oral HbF Inducer, pociredir, in SCD
Sunday, June 9, 2024
1:15 PM – 1:33 PM ET